Immunotherapy with Pembrolizumab in Metastatic Prostate Cancer: ASCO 2018 GU Highlights
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
Dr. Daniel Goldstein summarizes key data in genitourinary oncology from ASCO 2018, including new results ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
